HydRegen Closes $8 Million Series A to Scale Biocatalysis
HydRegen raised $8 million (£6 million) in Series A funding to bring biocatalysis into industrial chemical manufacturing, per BioSpace. The disclosure omits lead investor, valuation, and use of proceeds.